BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 26220860)

  • 21. Peripheral MRA with k-space segmentation and blood-pool contrast agent.
    Kinner S; Zenge MO; Heilmaier C; de Greiff A; Vogt FM; Ladd ME; Barkhausen J; Quick HH
    Acad Radiol; 2011 Jan; 18(1):113-9. PubMed ID: 20947388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of contrast-enhanced multi-station MR angiography and digital subtraction angiography of the lower extremity arterial disease.
    Burbelko M; Augsten M; Kalinowski MO; Heverhagen JT
    J Magn Reson Imaging; 2013 Jun; 37(6):1427-35. PubMed ID: 23188773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hybrid contrast-enhanced MR angiography of pelvic and lower extremity vasculature at 3.0 T: initial experience.
    Berg F; Bangard C; Bovenschulte H; Nijenhuis M; Hellmich M; Lackner K; Gossmann A
    Eur J Radiol; 2009 Apr; 70(1):170-6. PubMed ID: 18243622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Image Quality and Stenosis Assessment of Non-Contrast-Enhanced 3-T Magnetic Resonance Angiography in Patients with Peripheral Artery Disease Compared with Contrast-Enhanced Magnetic Resonance Angiography and Digital Subtraction Angiography.
    Liu J; Zhang N; Fan Z; Luo N; Zhao Y; Bi X; An J; Chen Z; Liu D; Wen Z; Fan Z; Li D
    PLoS One; 2016; 11(11):e0166467. PubMed ID: 27861626
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital heart disease: cardiovascular MR imaging by using an intravascular blood pool contrast agent.
    Makowski MR; Wiethoff AJ; Uribe S; Parish V; Botnar RM; Bell A; Kiesewetter C; Beerbaum P; Jansen CH; Razavi R; Schaeffter T; Greil GF
    Radiology; 2011 Sep; 260(3):680-8. PubMed ID: 21613441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for MR angiography of peripheral arteries.
    Gerretsen SC; le Maire TF; Miller S; Thurnher SA; Herborn CU; Michaely HJ; Kramer H; Vanzulli A; Vymazal J; Wasser MN; Ballarati CE; Kirchin MA; Pirovano G; Leiner T
    Radiology; 2010 Jun; 255(3):988-1000. PubMed ID: 20501735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral arterial occlusive disease: evaluation of a high spatial and temporal resolution 3-T MR protocol with a low total dose of gadolinium versus conventional angiography.
    Attenberger UI; Haneder S; Morelli JN; Diehl SJ; Schoenberg SO; Michaely HJ
    Radiology; 2010 Dec; 257(3):879-87. PubMed ID: 20959539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gadobenate dimeglumine and gadofosveset trisodium for MR angiography of the renal arteries: Multicenter intraindividual crossover comparison.
    Schneider G; Pasowicz M; Vymazal J; Seidl Z; Aschauer M; Konopka M; Bilecen D; Iezzi R; Ballarati C
    AJR Am J Roentgenol; 2010 Aug; 195(2):476-85. PubMed ID: 20651208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Contrast material for abdominal dynamic contrast-enhanced 3D MR angiography with parallel imaging: intraindividual equimolar comparison of a macrocyclic 1.0 M gadolinium chelate and a linear ionic 0.5 M gadolinium chelate.
    Hadizadeh DR; Von Falkenhausen M; Kukuk GM; Schöneseiffen K; Gieseke J; Schild HH; Willinek WA
    AJR Am J Roentgenol; 2010 Mar; 194(3):821-9. PubMed ID: 20173166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of gadofosveset trisodium and gadobenate dimeglumine during time-resolved thoracic MR angiography at 3T.
    Frydrychowicz A; Russe MF; Bock J; Stalder AF; Bley TA; Harloff A; Markl M
    Acad Radiol; 2010 Nov; 17(11):1394-400. PubMed ID: 20650665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-contrast-enhanced MR angiography at 3 Tesla in patients with advanced peripheral arterial occlusive disease.
    Thierfelder KM; Meimarakis G; Nikolaou K; Sommer WH; Schmitt P; Kazmierczak PM; Reiser MF; Theisen D
    PLoS One; 2014; 9(3):e91078. PubMed ID: 24608937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First-pass and equilibrium-MRA of the aortoiliac region with a superparamagnetic iron oxide blood pool MR contrast agent (SH U 555 C): results of a human pilot study.
    Tombach B; Reimer P; Bremer C; Allkemper T; Engelhardt M; Mahler M; Ebert W; Heindel W
    NMR Biomed; 2004 Nov; 17(7):500-6. PubMed ID: 15523717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Part 2 - Coronary angiography with gadofosveset trisodium: a prospective intra-subject comparison for dose optimization for 100 % efficiency imaging.
    Ahlman MA; Raman FS; Pang J; Zemrak F; Sandfort V; Penzak SR; Fan Z; Liu S; Li D; Bluemke DA
    BMC Cardiovasc Disord; 2016 Mar; 16():58. PubMed ID: 27004532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of infragenual arterial disease using non-contrast-enhanced MR angiography in patients with diabetes.
    Liu X; Zhang N; Fan Z; Feng F; Yang Q; Zheng H; Liu P; Li D
    J Magn Reson Imaging; 2014 Dec; 40(6):1422-9. PubMed ID: 24925770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of blood pool and extracellular gadolinium chelate for functional MR evaluation of vascular thoracic outlet syndrome.
    Lim RP; Bruno M; Rosenkrantz AB; Kim DC; Mulholland T; Kwon J; Palfrey AP; Ogedegbe O
    Eur J Radiol; 2014 Jul; 83(7):1209-1215. PubMed ID: 24840478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unmasking pedal arteries in patients with critical ischemia using time-resolved contrast-enhanced 3D MRA.
    Langer S; Krämer N; Mommertz G; Koeppel TA; Jacobs MJ; Wazirie NA; Ocklenburg C; Spüntrup E
    J Vasc Surg; 2009 May; 49(5):1196-202. PubMed ID: 19394548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuously moving table aorto-iliofemoral run-off contrast-enhanced magnetic resonance angiography: image quality analysis in comparison to the multistep acquisition.
    Asbach P; Meade MD; Sattenberg RJ; Klessen C; Huppertz A; Heidenreich JO
    Acta Radiol; 2014 Apr; 55(3):266-72. PubMed ID: 24078458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive MRA of the lower limbs including high-resolution extended-phase infra-inguinal imaging with gadobenate dimeglumine: initial experience with inter-individual comparison to the blood-pool contrast agent gadofosveset trisodium.
    Christie A; Chandramohan S; Roditi G
    Clin Radiol; 2013 Feb; 68(2):125-30. PubMed ID: 22884130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pedal angiography in peripheral arterial occlusive disease: first-pass i.v. contrast-enhanced MR angiography with blood pool contrast medium versus intraarterial digital subtraction angiography.
    Kos S; Reisinger C; Aschwanden M; Bongartz GM; Jacob AL; Bilecen D
    AJR Am J Roentgenol; 2009 Mar; 192(3):775-84. PubMed ID: 19234277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined blood pool and extracellular contrast agents for pediatric and young adult cardiovascular magnetic resonance imaging.
    Johnson JT; Robinson JD; Deng J; Rigsby CK
    Pediatr Radiol; 2016 Dec; 46(13):1822-1830. PubMed ID: 27576457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.